Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Schippa, Serena ^a   Iebba, Valerio ^a   Santangelo, Floriana ^a   Gagliardi, Antonella ^a   De Biase, Riccardo Valerio ^b   Stamato, Antonella ^b   Bertasi, Serenella ^b   Lucarelli, Marco ^b   Conte, Maria Pia ^a   Quattrucci, Serena ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; RNA 16S;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL OVERGROWTH; BIFIDOBACTERIUM; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; DNA EXTRACTION; ESCHERICHIA COLI; EUBACTERIUM; EUBACTERIUM BIFORME; EUBACTERIUM LIMOSUM; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; FECES MICROFLORA; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MALE; MECONIUM ILEUS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ADULT; ALLELES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DEMOGRAPHY; DISCRIMINANT ANALYSIS; ELECTROPHORESIS, AGAR GEL; FECES; FEMALE; GENOTYPING TECHNIQUES; HUMANS; LEAST-SQUARES ANALYSIS; MALE; METAGENOME; MIDDLE AGED; MUTATION; PHENOTYPE; RNA, RIBOSOMAL, 16S; SEVERITY OF ILLNESS INDEX; SPECIES SPECIFICITY; YOUNG ADULT;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; ESCHERICHIA COLI; EUBACTERIUM BIFORME; EUBACTERIUM LIMOSUM; FAECALIBACTERIUM PRAUSNITZII;

EID: 84876248314     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061176     Document Type: Article

References (48)

1. Castellani C, Cuppens H, Macek M Jr, Cassiman JJ, Kerem E, et al. (2008) Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 7: 179-196.
2. Davis PB, Drumm M, Konstan MW, (1996) Cystic fibrosis. Am J Respir Crit Care Med 154: 1229-1256.
3. Boucher RC, (2002) An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev 54: 1359-1371.
4. Ahmed N, Corey M, Forstner G, Zielenski J, Tsui LC, et al. (2003) Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 52: 1159-1164.
5. Rowntree RK, Harris A, (2003) The phenotypic consequences of CFTR mutations. Ann Hum Genet 67: 471-485.
6. Casaccia G, Trucchi A, Nahom A, Aite L, Lucidi V, et al. (2003) The impact of cystic fibrosis on neonatal intestinal obstruction: the need for prenatal/neonatal screening. Pediatr Surg Int 19: 75-78.
7. Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K, (2007) Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr 44: 212-218.
8. Khachatryan ZA, Ktsoyan ZA, Manukyan GP, Kelly D, Ghazaryan KA, et al. (2008) Predominant role of host genetics in controlling the composition of gut microbiota. PloS one 3: e3064.
9. Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, et al. (2011) Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 17: 179-184.
10. Lucarelli M, Narzi L, Piergentili R, Ferraguti G, Grandoni F, et al. (2006) A 96-well formatted method for exon and exon/intron boundary full sequencing of the CFTR gene. Anal Biochem 353: 226-235.
11. Borowitz D, Baker RD, Stallings V, (2002) Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 35: 246-259.
12. Lewiston N, Moss R, Hindi R, Rubinstein S, Sullivan M, (1987) Interobserver variance in clinical scoring for cystic fibrosis. Chest 91: 878-882.
13. Gibson LE, Cooke RE, (1959) A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 23: 545-549.
14. Nubel U, Engelen B, Felske A, Snaidr J, Wieshuber A, et al. (1996) Sequence heterogeneities of genes encoding 16S rRNAs in Paenibacillus polymyxa detected by temperature gradient gel electrophoresis. J Bacteriol 178: 5636-5643.
15. Wang RF, Cao WW, Cerniglia CE, (1996) PCR detection and quantitation of predominant anaerobic bacteria in human and animal fecal samples. Appl Environ Microbiol 62: 1242-1247.
16. Matsuki T, Watanabe K, Fujimoto J, Miyamoto Y, Takada T, et al. (2002) Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 68: 5445-5451.
17. Conte MP, Schippa S, Zamboni I, Penta M, Chiarini F, et al. (2006) Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 55: 1760-1767.
18. Marzorati M, Wittebolle L, Boon N, Daffonchio D, Verstraete W, (2008) How to get more out of molecular fingerprints: practical tools for microbial ecology. Environ Microbiol 10: 1571-1581.
19. Zoetendal EG, Akkermans AD, De Vos WM, (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64: 3854-3859.
20. Zoetendal EG, Cheng B, Koike S, Mackie RI, (2004) Molecular microbial ecology of the gastrointestinal tract: from phylogeny to function. Curr Issues Intest Microbiol 5: 31-47.
21. Ley RE, Peterson DA, Gordon JI, (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124: 837-848.
22. Li M, Wang B, Zhang M, Rantalainen M, Wang S, et al. (2008) Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 105: 2117-2122.
23. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, et al. (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107: 14691-14696.
24. Biasucci G, Rubini M, Riboni S, Morelli L, Bessi E, et al. (2010) Mode of delivery affects the bacterial community in the newborn gut. Early Hum Dev 86Suppl 1: 13-15.
25. Adlerberth I (2008) Factors influencing the establishment of the intestinal microbiota in infancy. Nestle Nutr Workshop Ser Pediatr Program 62: 13-29; discussion 29-33.
26. Iebba V, Aloi M, Civitelli F, Cucchiara S, (2011) Gut microbiota and pediatric disease. Dig Dis 29: 531-539.
27. Lees CW, Barrett JC, Parkes M, Satsangi J, (2011) New IBD genetics: common pathways with other diseases. Gut 60: 1739-1753.
28. Tizzano EF, Buchwald M, (1995) CFTR expression and organ damage in cystic fibrosis. Ann Intern Med 123: 305-308.
29. Pezzulo AA, Tang XX, Hoegger MJ, Alaiwa MH, Ramachandran S, et al. (2012) Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 487: 109-113.
30. Duytschaever G, Huys G, Bekaert M, Boulanger L, De Boeck K, et al. (2011) Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings. Appl Environ Microbiol 77: 8015-8024.
31. Wiuf C, (2001) Do delta F508 heterozygotes have a selective advantage? Genet Res 78: 41-47.
32. Iebba V, Conte MP, Lepanto MS, Di Nardo G, Santangelo F, et al. (2012) Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease. Infect Immun 80: 1408-1417.
33. Moore WE, Moore LH, (1995) Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 61: 3202-3207.
34. Schwiertz A, Le Blay G, Blaut M, (2000) Quantification of different Eubacterium spp. in human fecal samples with species-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 66: 375-382.
35. Le Blay G, Lacroix C, Zihler A, Fliss I, (2007) In vitro inhibition activity of nisin A, nisin Z, pediocin PA-1 and antibiotics against common intestinal bacteria. Lett Appl Microbiol 45: 252-257.
36. Schippa S, Iebba V, Barbato M, Di Nardo G, Totino V, et al. (2010) A distinctive 'microbial signature' in celiac pediatric patients. BMC Microbiol 10: 175.
37. Schippa S, Iebba V, Totino V, Santangelo F, Lepanto M, et al. (2012) A potential role of Escherichia coli pathobionts in the pathogenesis of pediatric inflammatory bowel disease. Can J Microbiol 58: 426-432.
38. Lee JM, Leach ST, Katz T, Day AS, Jaffe A, et al. (2012) Update of faecal markers of inflammation in children with cystic fibrosis. Mediators Inflamm 2012: 948367.
39. Packey CD, Sartor RB, (2009) Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 22: 292-301.
40. Chow J, Mazmanian SK, (2010) A pathobiont of the microbiota balances host colonization and intestinal inflammation. Cell Host Microbe 7: 265-276.
41. Chow J, Lee SM, Shen Y, Khosravi A, Mazmanian SK, (2010) Host-bacterial symbiosis in health and disease. Advances in immunology 107: 243-274.
42. Harper-Owen R, Dymock D, Booth V, Weightman AJ, Wade WG, (1999) Detection of unculturable bacteria in periodontal health and disease by PCR. J Clin Microbiol 37: 1469-1473.
43. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731-16736.
44. Roh H, Ko HJ, Kim D, Choi DG, Park S, et al. (2011) Complete genome sequence of a carbon monoxide-utilizing acetogen, Eubacterium limosum KIST612. J Bacteriol 193: 307-308.
45. Goddard AF, Staudinger BJ, Dowd SE, Joshi-Datar A, Wolcott RD, et al. (2012) Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci U S A 109: 13769-13774.
46. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, et al. (2010) Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PloS one 5: e11044.
47. Keely S, Talley NJ, Hansbro PM, (2012) Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol 5: 7-18.
48. Rogers GB, Carroll MP, Hoffman LR, Walker AW, Fine DA, et al. (2010) Comparing the microbiota of the cystic fibrosis lung and human gut. Gut Microbes 1: 85-93.